BackHikma Pharmaceuticals PLC Overview

Hikma Pharmaceuticals PLC Goodwill

Latest goodwill for HKMPF: $390M.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$389.00M
↓ 1.02% YoYΔ $-4.00M vs prior year quarter

Peer trimmed avg / median

Loading

Hikma Pharmaceuticals PLC Goodwill History

Loading

Hikma Pharmaceuticals PLC vs. peers: Goodwill Comparison

Loading

Hikma Pharmaceuticals PLC Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hikma Pharmaceuticals PLC (HKMPF) FAQ

Hikma Pharmaceuticals PLC posts a goodwill of $390M as of June 2026. That compares with $390M in the prior-year period — down 1.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Hikma Pharmaceuticals PLC's goodwill was $390M. The latest reading is $390M — a 1.0% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of Hikma Pharmaceuticals PLC's financial statement story. At $390M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for HKMPF's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Hikma Pharmaceuticals PLC's other metric pages and overview cover the third.